USPTO 2015–2025 USPTO PatentsView US Corporation

SOLAZYME, INC.

USPTO PatentsView assignee record — 26 granted patents across 35 technology areas, active 2015–2016. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C12P (FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE).

26
Total patents granted
35
CPC technology areas
14.9
Avg claims per patent
-100%
5-year filing velocity

Portfolio overview

SOLAZYME, INC. has been granted 26 US utility patents between 2015 and 2016, placing SOLAZYME, INC. at rank #11,801 across all assignees tracked by PlainPatent. This portfolio spans 35 distinct Cooperative Patent Classification (CPC) subclasses, averaging 14.9 claims per patent with primary concentration in C12P (FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE). As a US Corporation, SOLAZYME, INC. is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 41.3/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 0 grants, compared with 26 in the 2015–2019 window — a -100% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. SOLAZYME, INC.'s 14.9 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 35 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark SOLAZYME, INC. against peers pursuing similar technology classes.

How does SOLAZYME compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows SOLAZYME holds 26 patents — placing it at rank #11,801 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

USPTO utility patent grants by year · 2015–2016

10111213141516 20152016 11
USPTO utility patent grants by year · 2015–2016

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
SOLAZYME, INC. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 15 57.7%
2016 11 42.3%

Which technologies does SOLAZYME, INC. patent most?

Top 15 of 35 technology areas

Patent Moat Analysis

Portfolio Volume Light
Tech Breadth Multi-domain
Claim Depth Standard
Velocity Declining

Where it ranks

Overall rank by patents

#11,801

Across all tracked assignees

Innovation Score

41.3 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does SOLAZYME, INC. hold?
SOLAZYME, INC. holds 26 US granted patents filed between 2015 and 2016, spanning 35 technology areas.
What is SOLAZYME, INC.'s Innovation Score?
SOLAZYME, INC. has an Innovation Score of 41.3 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does SOLAZYME, INC. focus on?
SOLAZYME, INC.'s top technology area is C12P (FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE) with 22 patents. The company has filed patents in 35 CPC subclasses total.
Is SOLAZYME, INC.'s patent filing rate increasing or decreasing?
SOLAZYME, INC.'s recent filing velocity is -100% compared to the prior five-year period. Filing activity has slowed relative to earlier years.
What does claim depth mean for SOLAZYME, INC.'s patents?
SOLAZYME, INC.'s patents average 14.9 claims each. This falls within the standard range, providing solid legal coverage.
How is the SOLAZYME, INC. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

Explore the patent dataset

Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

All federal data sources used on this page
  • USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
  • USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
  • USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
  • USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
  • SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
  • WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope